Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.54%
#6 Wrapped Krown Wrapped Krown +20.00%
#7 Talus Network Talus Network +19.98%
#8 DODO DODO +17.78%
#9 Black Phoenix Black Phoenix +15.09%
#10 Magma Finance Magma Finance +14.74%
Coin of the day
DeFiChain DeFiChain
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Classificação em ações #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Preço da ação
$0.94180721
Valor de mercado
$22.26M
Variação (1 dia)
0.38%
Variação (1 ano)
-14.35%
País
FR
Negociar Valbiotis SA (ALVAL)

Categoria

Healthcare
Rácio P/S de Valbiotis SA (ALVAL)
Rácio P/S em July 2026 TTM: 20.66
De acordo com os relatórios financeiros mais recentes e o preço das ações da Valbiotis SA, o rácio P/S atual (TTM) é 20.66. No final de 2023, o rácio P/S era 13.17.
Histórico do rácio P/S da Valbiotis SA de 2015 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
2026 (TTM) 20.66 -84.94%
2024 137.18 942.04%
2023 13.17 -71.62%
2022 46.39 -77.96%
2021 210.51 1,341.15%
2020 14.61 -87.37%
2019 115.65 -24.97%
2018 154.14 -97.25%
2017 5.61K 10,113.84%
2016 54.92 355.39%
2015 12.06 0.00%
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.33 -79.03%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.86 -52.26%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.53 -78.07%
US
UCB SA UCB SA
UCB SA
UCB.BR
5.72 -72.33%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.03 -22.43%
NL